Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - paracetamol - otopina za infuziju - 10 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 10 mg paracetamola

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

b. braun adria d.o.o., hondlova 2/9, zagreb - natrijev klorid kalijev klorid kalcijev klorid dihidrat - otopina za infuziju - 8,6 g + 0,3 g +0,33 g/1000 ml - urbroj: 1000 ml otopine sadrži 8,60 g natrijevog klorida, 0,30 g kalijevog klorida i 0,33 g kalcijevog klorid dihidrata

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

noucor health s.a., avinguda del cami reial 51-57, palau-solita i plegamans, barcelona, Španjolska - rupatadinfumarat - oralna otopina - 1 mg/ml - urbroj: 1 ml oralne otopine sadržava 1 mg rupatadina (u obliku fumarata)

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

noucor health s.a., avinguda del cami reial 51-57, palau-solita i plegamans, barcelona, Španjolska - rupatadinfumarat - tableta - 10 mg - urbroj: jedna tableta sadržava 10 mg rupatadina (u obliku fumarata)

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 100 mg - urbroj: svaka tvrda kapsula sadrži 100 mg zonisamida

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 25 mg - urbroj: svaka tvrda kapsula sadrži 25 mg zonisamida

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 50 mg - urbroj: svaka tvrda kapsula sadrži 50 mg zonisamida

Evropská unie - chorvatština - EMA (European Medicines Agency)

gilead sciences ireland uc - bictegravir, эмтрицитабин, Тенофовир alafenamide, фумарат - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (vidi odjeljak 5.

Evropská unie - chorvatština - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Evropská unie - chorvatština - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudin, Тенофовир дизопроксил фумарат - hiv infekcije - antivirusni lijekovi za liječenje hiv infekcija, kombinacija - delstrigo indiciran za liječenje odraslih osoba zaraženih hiv-1, bez prošlosti ili ovih dokaza otpornost do klase ННИОТ, lamivudin ili Тенофовир. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.